Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Tonglu Huifeng Biosciences is a China-based biochemical and biopesticide manufacturer headquartered in Tonglu, Hangzhou, Zhejiang. The company is best known as an early and large domestic producer of validamycin in China and also manufactures abamectin, Bacillus thuringiensis products, and related pesticide formulations. Its business appears centered on industrial microbiological fermentation, production, and export of agricultural biochemical products rather than human therapeutics. Although some directories mention activity in bio-pharmaceutical fields, the available evidence points primarily to a commercial agrochemical and biopesticide business with manufacturing and R&D capabilities. The company exports to multiple countries and operates production assets and affiliated factories in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Tonglu Huifeng Biosciences.